Upon CPG2-mediated hydrolysis of the TMN-CPG amide bond, the highly fluorescent TMN-NH<sub>2</sub> is released and subsequently internalized by cancer cells, resulting in tumor-specific fluorescence. The gene discussed is SYNE1; the disease is cancer.